Valerie Jane Harahush

Bain Capital Public Equity LP is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1996 as Brookside Capital LP. They are wholly-owned by Bain Capital LP, itself a subsidiary of Bain Capital Holdings LP. Bain Capital Public Equity provides investment advisory services to pooled investment vehicles (Public Equity Funds). Investors in the Public Equity Funds includes high net-worth individuals, banks, thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, university endowments, corporations, limited partnerships and limited liability companies or other business entities.

The Depository Trust & Clearing Corp. provides clearance, settlement and information services. The firm offers institutional trade processing, clearing, settlement and asset, wealth management, repository and derivatives and data services. The company was founded in 1999 is headquartered in New York, NY.

Omgeo LLC develops trade management software solutions. Is solutions include fixed income, equities, derivatives, repurchase agreements, managed accounts and private wealth. The company was founded in 2001 and is headquartered in Boston, MA.

Sculptor Capital Management Europe Ltd. (Sculptor Capital Europe) is the wholly-owned, Great Britain-based alternative asset management subsidiary of Sculptor Capital LP, itself a subsidiary of Sculptor Capital Management, Inc. (NYSE: SCU) in the US. The firm was founded in 1998 and was formerly known as Och-Ziff Management Europe Ltd. Headquartered in London, Sculptor Capital Europe manages alternative investments for individuals, family offices, pensions, foundation and endowments, private banks, funds of funds, corporate and other institutional clients.

DTCC Derivatives Repository PLC operates as a trade repository which provides a suite of post-trade record-keeping and reporting services for over the counter (OTC) equity, credit, and interest rates derivatives, bringing greater transparency, resultant risk mitigation, and cost-efficiency to the global OTC derivatives market. The company was founded on June 9, 2010 and is headquartered in London, the United Kingdom.